Texas A&M Study Redirects Mammalian Fibroblasts to Form Blastema-Like Structures via Sequential FGF2-BMP2 Treatment

The team applied FGF2 post-closure to induce blastema-like aggregates from local fibroblasts, then BMP2 to drive positional re-specification and tissue patterning. This avoided exogenous stem cells entirely, instead exploiting endogenous cells already at the injury site. Sample sizes were modest rodent cohorts with histological and micro-CT endpoints confirming partial but organized skeletal and connective tissue restoration. The work builds on Muneoka's prior digit regeneration studies and parallels salamander blastema mechanics without requiring phylogenetic comparisons.

Prior coverage emphasized scar-versus-regeneration duality but overlooked how timing of FGF2 after epithelialization prevents premature fibrosis while enabling positional information reset. This reframes mammalian healing not as a binary loss but as a tunable process, linking to broader fibroblast plasticity seen in wound healing transcriptomics and challenging stem-cell-centric regenerative strategies.

Long-term implications include reduced amputation morbidity and potential extension to aging-related tissue decline if dosing windows and factor combinations can be refined. Next steps require larger animal models with functional load-bearing tests and single-cell tracking to confirm lineage contributions.

Key limitation remains incomplete morphological fidelity; strengthening evidence demands blinded multi-center replication in non-rodent mammals with quantified biomechanical outcomes.